Abstract

Purpose: To examine the dynamics of depressive and psychosomatic symptoms with hyperbaric oxygenation in therapy of patients with long COVID-19. Material and Methods: Patients with long COVID-19 (n = 52) who underwent 15 sessions of hyperbaric oxygenation in the Polyclinic No. 2 of the Federal State Budgetary Institution Federal Medical and Biological Center of Russia completed the Giessen questionnaire for self-assessment of psychosomatic symptoms before and after therapy. The patient depressive symptoms were also assessed before and after therapy by psychiatrists using the Hamilton Rating Scale for Depression. Results: The results showed a decrease in depressive symptoms, exhaustion, gastric and cardiac complaints, and overall symptom pressure after hyperbaric oxygen therapy. Rheumatic factor appeared to be the only psychosomatic symptom that did not decrease after therapy. Conclusion: Overall, depressive and psychosomatic symptoms are persistent with long COVID-19, and hyperbaric oxygenation may be effective in treating this symptomatology.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call